B
BOLD
BOUNDLESS BIO INC
2.360
-0.080-3.28%After Hours: 2.360 0.000 0.00%16:10 10/23 EDT
OPEN/PREV CLOSE2.410/2.440
TODAY RANGE2.345-2.440
VOL34.87K
MARKET CAP54.54M
52 WEEK RANGE0.9612-3.164
AVG VOL (3M)178.79K
% TURNOVER0.14%
TURNOVER--
P/E (TTM)-0.8265
% RANGE3.69%
EPS(TTM)-2.8555
P/E(FORWARD)-0.9328
P/B0.8040
BVPS2.936
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP47.81M
SHARES OUTSTANDING23.11M
NEXT EARNINGS11/03-11/09
FREE FLOAT20.26M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·09/30 16:11
Beam alleges Chinese biotech, and its U.S. partner Serapha stole trade secrets
Seeking Alpha·09/29 11:30
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
TipRanks·08/29 02:07
Major Investor Shakes Up Boundless Bio With Fresh Stock Sale
TipRanks·08/28 21:48
Boundless Bio Amends Merger Agreement with Serapha Bio
TipRanks·07/22 02:01
Major Investor Quietly Boosts Stake in Emerging Biotech Player
TipRanks·07/03 02:02
Major Investor Doubles Down on Boundless Bio With Bold New Stock Purchase
TipRanks·06/30 02:02
Major Investor Makes Bold Move on Boundless Bio Shares
Seeking Alpha·06/26 12:40
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade)
TipRanks·06/23 13:43
Boundless Bio, Serapha Bio to combine in all-stock merger
TipRanks·06/23 13:32
Boundless Bio to Merge with Serapha Bio, Restructure Operations
Seeking Alpha·06/23 11:59
Boundless Bio to merge with Serapha Bio in reverse merger; shares surge
TipRanks·06/17 15:18
Boundless Bio Shareholders Back Directors and Auditor Appointments
TipRanks·06/08 16:31
Boundless Bio Halts Early Cancer Trial, Resetting Expectations for BOLD
Same Industry
Name/Symbol
Change%
Price